FONR vs JNJ · P/E 19, rev $104.4M vs P/E 17, rev $49.37B
Fonar Corporation (FONR) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Fonar Corporation (FONR) is a diagnostics & research company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported FONR revenue for 2025-06-30 was $104.4M. Net income was $8.3M. Revenue was up 1.4% from 2024-06-30 to 2025-06-30. FONR currently screens at market cap $120.2M and trailing P/E 19.1.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
FONR currently screens at market cap $120.2M and trailing P/E 19.1. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the FONR and JNJ stock pages for the full models.
Not investment advice.